Inhibition of the alloimmune response with synthetic nonpolymorphic class II MHC peptides.
Murphy
B
B
Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
Akalin
E
E
Watschinger
B
B
Carpenter
C B
CB
Sayegh
M H
MH
D000595:Amino Acid Sequence; D000818:Animals; D003602:Cytotoxicity, Immunologic; D000949:Histocompatibility Antigens Class II / Q000276:immunology / Q000494:pharmacology*; D008198:Lymph Nodes / Q000276:immunology; D008213:Lymphocyte Activation; D007959:Lymphocyte Culture Test, Mixed; D008297:Male; D008969:Molecular Sequence Data; D010446:Peptide Fragments / Q000138:chemical synthesis / Q000494:pharmacology*; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D011920:Rats, Inbred WF; D013601:T-Lymphocytes / Q000276:immunology*; D013602:T-Lymphocytes, Cytotoxic
D000949:Histocompatibility Antigens Class II; D010446:Peptide Fragments